查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
聚合□链反应市场规模、份额和趋势分析报告：按类型（常规 PCR）、按产品（仪器、耗材/试剂、软件/服务）、按应用、按地区、按细分市场、预测 2022-2030 年
市场调查报告书
商品编码
1114090

聚合□链反应市场规模、份额和趋势分析报告：按类型（常规 PCR）、按产品（仪器、耗材/试剂、软件/服务）、按应用、按地区、按细分市场、预测 2022-2030 年

Polymerase Chain Reaction Market Size, Share & Trends Analysis Report By Type (Conventional PCR), By Product (Instruments, Consumables & Reagents, Software & Services), By Application, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10个工作天内

价格

聚合□炼式反应市场增长和趋势

Grand View Research, Inc. 的一份新报告显示，到 2030 年，全球聚合□炼式反应市场预计将达到 184.4 亿美元。

预计从 2022 年到 2030 年，复合年增长率为 7.5%。对聚合□炼式反应 (PCR) 测试的需求将受到对先进诊断技术的需求增加、法医和研究应用的增加以及慢性病、传染病和遗传病等疾病的日益流行的推动。基因检测需求的增加和新技术的引入也是推动 PCR 检测需求增加的主要因素。

由于先进诊断测试越来越多地采用以及 PCR 技术在医疗和非医疗应用中越来越多地采用等因素，预计该市场将出现增长机会。此外，新技术的推出、CRO 的增加以及研究机构和法医实验室的增加预计将在预测期内推动需求向前发展。多个研究机构和 CRO 正在开展基于基因组学的研究，以製定疾病管理的创新策略。

引进新技术和技术先进的检查正在创造新的增长机会。例如，2021 年 1 月，GeneIQ 宣布推出 4 合 1 PCR 检测，检测乙型流感 (Flu B)、甲型流感 (Flu A)、呼吸道合胞病毒 (RSV) 和 SARS-CoV-2。同样，2020 年 12 月，美纳里尼诊断公司推出了一项用于区分流感和 SARS-CoV-2 的分子检测。这些努力将增加对新型 PCR 测试的需求。

政府机构实施的有利举措正在推动参与者开髮用于各种应用的新型分子测试。例如，2020 年 1 月，在欧盟/EFPIA 创新药物倡议联合承诺下，赫尔辛基大学与欧盟合作，资助了一项评估 qPCR 以进行微生物群分析的研究。在本研究中，使用 iCycler iQ 热循环仪系统和 HOT FIREPol EvaGreen qPCR Mix Plus 对梭菌簇 XIVa 进行了研究。此外，2020 年 3 月，国际原子能机构 (IAEA) 宣布与联合国粮食及农业组织 (FAO) 建立合作伙伴关係，以支持使用逆转录 PCR。

一些公司正在采取收购等战略来巩固自己的地位。收购有助于加强公司的产品供应、能力和竞争力。例如，2021 年 1 月，赛默飞世尔科技宣布以 4.5 亿美元收购分子诊断公司 Mesa Biotech，以加强其产品组合。因此，预计公司采用的各种策略将在预测期内推动需求向前发展。

聚合□炼式反应市场报告亮点

2021 年，由于 PCR 在临床诊断和药物开发和研究中的应用越来越多，医疗应用主导了市场。

耗材和试剂产品部门预计将在 2021 年占据最大的收入份额，并在预测期内保持其主导地位

由于存在有利的法规以及政府实施的有关医疗保健基础设施进步的各种举措以及该地区疾病的高流行率，北美在 2021 年主导了市场。

内容

第1章调查方法及范围

  • 市场细分
    • 段范围
    • 区域范围
    • 估计/预测时间表
  • 调查方法
  • 信息采购
    • 购买的数据库
    • Gvr 内部数据库
    • 辅助信息
    • 初步调查
    • 初步调查的详细信息
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法 1：商品流通方法
      • 方法 2：使用自下而上的方法估算国别市场
      • 方法 3：使用自上而下的方法估算各国市场
  • 全球市场：CAGR 计算
  • 调查假设
  • 主要 KoL 回应
  • 市场份额的计算
  • 辅助信息列表
  • 目的
  • 缩写列表

第 2 章执行摘要

  • 市场概览

第 3 章 PCR 市场 - 行业展望

  • 市场系列展望
    • 母市场谱系预测
    • 相关/子公司市场展望
  • 绘製渗透率和增长前景
  • 市场动态
    • 市场驱动力
      • 慢性病、传染病和遗传病的发病率不断上升
      • PCR技术进展
      • MIQE 指南的实施
      • 对快速诊断检测的需求不断增加，PCR 技术的采用率越来越高
      • 增加 CRO 以及法医和调查机构的数量
      • 对产前基因检测程序的需求不断增加
      • COVID-19 爆发
    • 市场约束分析
      • qPCR 设备成本高
      • 严格的监管政策
  • 按因素（政治和法律、经济和技术）进行 SWOT 分析
  • 行业分析 - 搬运工
  • 报销和监管方案
  • 重大交易和战略联盟
    • 推出新产品
    • 获取
    • 扩展名
    • 合作伙伴关係
    • 营销和推广
      • 市场进入策略
    • 分析未满足的需求
      • 快速诊断的必要性
      • 实惠的价格
      • 病原体检测范围有限
    • 新 PCR 设备推出后市场动态的变化
      • 医药
      • 非医疗
    • 现有 PCR 和等离子 PCR 的比较
      • COVID-19 的可能性
    • 消费者行为分析

第 4 章 PCR 市场分析：Typescope，2018-2030 年（收入，百万美元）

  • PCR 市场：类型变异分析
  • 常规 PCR
  • 其他

第 5 章 PCR 市场分析：2018-2030 年产品范围（收入，百万美元）

  • PCR 市场：产品变异分析
  • 消耗品和试剂
  • 仪器
  • 软件和服务

第 6 章 PCR 市场分析：2018-2030 年范围（收入，百万美元）

  • PCR 市场：应用变异分析
  • 医药
    • 临床
      • 病原体检测
      • 肿瘤科检查
      • 血液筛查
      • 其他
    • 调查
    • 取证等
  • 非医疗
    • 食物
    • 其他

第 7 章 PCR 市场分析，区域范围，2018-2030，（收入，百万美元）

  • 2021 年和 2030 年按国家/地区分列的市场份额分析
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 法国
      • 意大利
      • 西班牙
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 澳大利亚
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中东和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯联合酋长国

第 8 章 PCR 市场：竞争分析

  • 主要市场参与者的近期趋势和影响分析
    • 安索夫矩阵`
  • 公司分类
    • 创新者
      • 市场差异化因素
  • 供应商情况
    • 主要分销商和渠道合作伙伴列表
    • 主要客户
    • 2021 年主要参与者的市场份额分析
  • 上市公司
    • 竞争信息中心分析
  • 私人公司
    • 主要初创企业列表
  • 本地网络地图
  • PCR 耗材/□在日本、澳大利亚、韩国、印度、新加坡和欧洲的主要区域/区域竞争对手
  • 公司简介
    • 雅培
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • QIAGEN
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • BIO-RAD 实验室, INC.
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • 安捷伦科技公司
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Thermo Fisher Scientific, Inc.
      • 公司简介
      • Affymetrix
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • CYTIVA（GE 医疗保健）
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • BIOMERIEUX SA
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • F. HOFFMANN-LA ROCHE LTD.
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • 流体公司
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • 斯蒂拉
      • 公司简介
      • 产品基准
      • 战略举措
    • MICROSYNTH AG
      • 公司简介
      • 产品基准
      • 战略举措
    • JN MEDSYS
      • 公司简介
      • 产品基准
      • 战略举措
    • 丹纳赫公司
      • 公司简介
      • 造父变
      • 贝克曼库尔特
      • 徕卡生物系统
      • 财务表现
      • 产品基准
      • 战略举措
Product Code: GVR-4-68039-188-0

Polymerase Chain Reaction Market Growth & Trends:

The global polymerase chain reaction market size is expected to reach USD 18.44 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 7.5% from 2022 to 2030. The demand for polymerase chain reaction (PCR) testing is expected to be driven by the increasing demand for advanced diagnostic techniques; rising forensic and research applications; and the growing prevalence of diseases such as chronic diseases, infectious diseases, and genetic disorders. Moreover, increasing demand for genetic testing procedures and the introduction of novel technologies are other key factors likely to increase the demand for PCR testing.

The market is expected to witness growth opportunities owing to factors such as the increasing adoption of advanced diagnostic tests and the growing adoption of PCR technologies in medical and non-medical applications. Moreover, the launch of novel technologies, an increasing number of CROs, and research and forensic laboratories are expected to propel the demand forward during the forecast period. Several research institutes and CROs are involved in genomics-based research to develop innovative strategies for disease management.

The introduction of novel and technologically advanced tests is opening new growth opportunities. For instance, in January 2021, GeneIQ announced the launch of its 4-in-1 PCR test for the detection of influenza B (Flu B), influenza A (Flu A), respiratory syncytial virus (RSV), and SARS-CoV-2. Similarly, in December 2020, Menarini Diagnostics launched a molecular test that is used to distinguish between Flu and SARS-CoV-2. Such initiatives will increase the demand for novel PCR tests.

Favorable initiatives undertaken by government bodies are encouraging the players to develop novel molecular tests for different applications. For instance, in January 2020, the University of Helsinki in collaboration with the European Union under the EU/EFPIA Innovative Medicines Initiative Joint Undertaking, funded research for the assessment of qPCR for microbiota profiling. In the study, the iCycler iQ thermal cycler system was used with HOT FIREPol EvaGreen qPCR Mix Plus for studying Clostridium cluster XIVa. Moreover, in March 2020, International Atomic Energy Agency (IAEA) announced a partnership with the Food and Agriculture Organization of the United Nations (FAO) for supporting the use of reverse transcription-PCR.

Several companies are adopting strategies such as acquisitions for strengthening their positions. Acquisition assists companies to enhance their offerings, capabilities, and competencies. For instance, in January 2021, Thermo Fisher Scientific, Inc. announced that it has acquired Mesa Biotech, Inc. - a molecular diagnostic company for USD 450 million to strengthen its product portfolio. Thus, various strategies adopted by companies are anticipated to propel the demand forward over the forecast period.

Polymerase Chain Reaction Market Report Highlights:

  • In 2021, the medical application segment dominated the market owing to the rising application of PCR in clinical diagnostics and drug development and research
  • The consumables and reagents product segment held the largest revenue share in 2021 and is expected to retain its dominance over the forecast period
  • North America dominated the market in 2021 due to the presence of favorable regulations and various initiatives about the advancements in healthcare infrastructure undertaken by the government and the high prevalence of diseases in the region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
      • 1.6.1.3 Approach 3: Country-wise market estimation using top-down approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 Key KoL Responses
  • 1.10 Market Share Calculations
  • 1.11 List of Secondary Sources
  • 1.12 Objectives
    • 1.12.1 Objective 1:
    • 1.12.2 Objective 2:
  • 1.13 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 PCR Market - Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Rising incidence of chronic diseases, infectious diseases, and genetic disorders
      • 3.3.1.2 Technological advancements in PCR
      • 3.3.1.3 Implementation of MIQE guidelines
      • 3.3.1.4 Increasing demand for rapid diagnostic tests and growing adoption of PCR technologies
      • 3.3.1.5 Increasing number of CROs and forensic & research laboratories
      • 3.3.1.6 Increasing demand for prenatal genetic testing procedures
      • 3.3.1.7 Outbreak of COVID-19
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 High qPCR device costs
      • 3.3.2.2 Stringent regulatory policies
  • 3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions
      • 3.7.5.1 Market entry strategies
    • 3.7.6 Unmet Need Analysis
      • 3.7.6.1 Need for rapid diagnosis
      • 3.7.6.2 Affordability
      • 3.7.6.3 Limited scope of pathogen detection
    • 3.7.7 Change In Market Dynamics After The Launch Of Novel PCR Devices
      • 3.7.7.1 Medical
      • 3.7.7.2 Non-Medical
    • 3.7.8 Comparison Of Existing PCR With Plasmonic PCR
      • 3.7.8.1 Potential for COVID-19
    • 3.7.9 Consumer Behavior Analysis

Chapter 4 PCR Market Analysis: Type Scope, 2018 - 2030 (Revenue, USD Million)

  • 4.1 PCR Market: Type Movement Analysis
  • 4.2 Conventional PCR
    • 4.2.1 Conventional PCR Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.3 Others
    • 4.3.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 PCR Market Analysis: Product Scope, 2018 - 2030 (Revenue, USD Million)

  • 5.1 PCR Market: Product Movement Analysis
  • 5.2 Consumables & Reagents
    • 5.2.1 Consumables & Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Instruments
    • 5.3.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Software & Services
    • 5.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 PCR Market Analysis: Application Scope, 2018 - 2030 (Revenue, USD Million)

  • 6.1 PCR Market: Application Movement Analysis
  • 6.2 Medical
    • 6.2.1 Medical Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Clinical
    • 6.2.3 Clinical Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.3.1 Pathogen Testing
      • 6.2.3.1.1 Pathogen Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.3.2 Oncology Testing
      • 6.2.3.2.1 Oncology Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.3.3 Blood Screening
      • 6.2.3.3.1 Blood Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.3.4 Others
      • 6.2.3.4.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.4 Research
      • 6.2.4.1 Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.5 Forensics And Others
      • 6.2.5.1 Forensics and other market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3 Non-medical
    • 6.3.1 Non-Medical Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2 Food
      • 6.3.2.1 Food Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.3 Others
      • 6.3.3.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 PCR Market Analysis, Regional Scope, 2018 - 2030, (Revenue, USD Million)

  • 7.1 Market Share Analysis by Country, 2021 & 2030
    • 7.1.1 North America
      • 7.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.1.2 U.S.
      • 7.1.1.2.1 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.1.3 Canada
      • 7.1.1.3.1 Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.1.2 Europe
      • 7.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.2 U.K.
      • 7.1.2.2.1 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.3 Germany
      • 7.1.2.3.1 Germany market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.4 France
      • 7.1.2.4.1 France market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.5 Italy
      • 7.1.2.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.2.6 Spain
      • 7.1.2.6.1 Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.1.3 Asia Pacific
      • 7.1.3.1 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.2 Japan
      • 7.1.3.2.1 Japan market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.3 China
      • 7.1.3.3.1 China market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.4 India
      • 7.1.3.4.1 India market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.5 South Korea
      • 7.1.3.5.1 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.3.6 Australia
      • 7.1.3.6.1 Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.1.4 Latin America
      • 7.1.4.1 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.4.2 Brazil
      • 7.1.4.2.1 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.4.3 Mexico
      • 7.1.4.3.1 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.4.4 Argentina
      • 7.1.4.4.1 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.1.5 Middle East And Africa
      • 7.1.5.1 Middle East & Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.5.2 South Africa
      • 7.1.5.2.1 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.5.3 Saudi Arabia
      • 7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.1.5.4 UAE
      • 7.1.5.4.1 UAE market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 PCR Market: Competitive Analysis

  • 8.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 8.1.1 Ansoff Matrix`
  • 8.2 Company Categorization
    • 8.2.1 Innovators
      • 8.2.1.1 Market Differentiators
  • 8.3 Vendor Landscape
    • 8.3.1 List Of Key Distributors And Channel Partners
    • 8.3.2 Key Customers
    • 8.3.3 Key Company Market Share Analysis, 2021
  • 8.4 Public Companies
    • 8.4.1 Competitive Dashboard Analysis
  • 8.5 Private Companies
    • 8.5.1 List Of Key Emerging Companies
  • 8.6 Regional Network Map
  • 8.7 Key Regional/Local Competitors for PCR Consumables/Enzymes in Japan, Australia, Korea, India, Singapore, and Europe
  • 8.8 Company Profiles
    • 8.8.1 ABBOTT
      • 8.8.1.1 Company overview
      • 8.8.1.2 Financial performance
      • 8.8.1.3 Product benchmarking
      • 8.8.1.4 Strategic initiatives
    • 8.8.2 QIAGEN
      • 8.8.2.1 Company overview
      • 8.8.2.2 Financial performance
      • 8.8.2.3 Product benchmarking
      • 8.8.2.4 Strategic initiatives
    • 8.8.3 BIO-RAD LABORATORIES, INC.
      • 8.8.3.1 Company overview
      • 8.8.3.2 Financial performance
      • 8.8.3.3 Product benchmarking
      • 8.8.3.4 Strategic initiatives
    • 8.8.4 AGILENT TECHNOLOGIES, INC.
      • 8.8.4.1 Company overview
      • 8.8.4.2 Financial performance
      • 8.8.4.3 Product benchmarking
      • 8.8.4.4 Strategic initiatives
    • 8.8.5 THERMO FISHER SCIENTIFIC, INC.
      • 8.8.5.1 Company overview
      • 8.8.5.2 Affymetrix
      • 8.8.5.3 Company overview
      • 8.8.5.4 Financial performance
      • 8.8.5.5 Product benchmarking
      • 8.8.5.6 Strategic initiatives
    • 8.8.6 CYTIVA (GE HEALTHCARE)
      • 8.8.6.1 Company overview
      • 8.8.6.2 Financial performance
      • 8.8.6.3 Product benchmarking
      • 8.8.6.4 Strategic initiatives
    • 8.8.7 BIOMERIEUX SA
      • 8.8.7.1 Company overview
      • 8.8.7.2 Financial performance
      • 8.8.7.3 Product benchmarking
      • 8.8.7.4 Strategic initiatives
    • 8.8.8 F. HOFFMANN-LA ROCHE LTD.
      • 8.8.8.1 Company overview
      • 8.8.8.2 Financial performance
      • 8.8.8.3 Product benchmarking
      • 8.8.8.4 Strategic initiatives
    • 8.8.9 FLUIDIGM CORPORATION
      • 8.8.9.1 Company overview
      • 8.8.9.2 Financial performance
      • 8.8.9.3 Product benchmarking
      • 8.8.9.4 Strategic initiatives
    • 8.8.10 STILLA
      • 8.8.10.1 COMPANY OVERVIEW
      • 8.8.10.2 Product benchmarking
      • 8.8.10.3 Strategic initiatives
    • 8.8.11 MICROSYNTH AG
      • 8.8.11.1 Company overview
      • 8.8.11.2 Product benchmarking
      • 8.8.11.3 Strategic initiatives
    • 8.8.12 JN MEDSYS
      • 8.8.12.1 Company overview
      • 8.8.12.2 Product benchmarking
      • 8.8.12.3 Strategic initiatives
    • 8.8.13 DANAHER CORPORATION
      • 8.8.13.1 Company overview
      • 8.8.13.2 Cepheid
      • 8.8.13.3 Beckman Coulter
      • 8.8.13.4 Leica Biosystems
      • 8.8.13.5 Financial performance
      • 8.8.13.6 Product benchmarking
      • 8.8.13.7 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 Incidence of diseases
  • Table 4 EUA (Emergency Use Authorization) PCR tests for COVID-19
  • Table 5 EUA (Emergency Use Authorization) molecular diagnostics tests for COVID-19 in 2021
  • Table 6 Comparison of existing PCR with Plasmonic PCR
  • Table 7 Real-time RT-PCR kits with EUA for COVID-19
  • Table 8 PCR systems with EUA for COVID-19
  • Table 9 North America PCR market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America PCR market, by type, 2018 - 2030 (USD Million)
  • Table 11 North America PCR market, by product, 2018 - 2030 (USD Million)
  • Table 12 North America PCR market, by application, 2018 - 2030 (USD Million)
  • Table 13 U.S. PCR market, by type, 2018 - 2030 (USD Million)
  • Table 14 U.S. PCR market, by product, 2018 - 2030 (USD Million)
  • Table 15 U.S. PCR market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada PCR market, by type, 2018 - 2030 (USD Million)
  • Table 17 Canada PCR market, by product, 2018 - 2030 (USD Million)
  • Table 18 Canada PCR market, by application, 2018 - 2030 (USD Million)
  • Table 19 Europe PCR market, by Country, 2018 - 2030 (USD Million)
  • Table 20 Europe PCR market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe PCR market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe PCR market, by application, 2018 - 2030 (USD Million)
  • Table 23 U.K. PCR market, by type, 2018 - 2030 (USD Million)
  • Table 24 U.K. PCR market, by product, 2018 - 2030 (USD Million)
  • Table 25 U.K. PCR market, by application, 2018 - 2030 (USD Million)
  • Table 26 Germany PCR market, by type, 2018 - 2030 (USD Million)
  • Table 27 Germany PCR market, by product, 2018 - 2030 (USD Million)
  • Table 28 Germany PCR market, by application, 2018 - 2030 (USD Million)
  • Table 29 France PCR market, by type, 2018 - 2030 (USD Million)
  • Table 30 France PCR market, by product, 2018 - 2030 (USD Million)
  • Table 31 France PCR market, by application, 2018 - 2030 (USD Million)
  • Table 32 Italy PCR market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy PCR market, by product, 2018 - 2030 (USD Million)
  • Table 34 Italy PCR market, by application, 2018 - 2030 (USD Million)
  • Table 35 Spain PCR market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain PCR market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain PCR market, by application, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific PCR market, by Country, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific PCR market, by type, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific PCR market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific PCR market, by application, 2018 - 2030 (USD Million)
  • Table 42 Japan PCR market, by type, 2018 - 2030 (USD Million)
  • Table 43 Japan PCR market, by product, 2018 - 2030 (USD Million)
  • Table 44 Japan PCR market, by application, 2018 - 2030 (USD Million)
  • Table 45 China PCR market, by type, 2018 - 2030 (USD Million)
  • Table 46 China PCR market, by product, 2018 - 2030 (USD Million)
  • Table 47 China PCR market, by application, 2018 - 2030 (USD Million)
  • Table 48 India PCR market, by type, 2018 - 2030 (USD Million)
  • Table 49 India PCR market, by product, 2018 - 2030 (USD Million)
  • Table 50 India PCR market, by application, 2018 - 2030 (USD Million)
  • Table 51 Australia PCR market, by type, 2018 - 2030 (USD Million)
  • Table 52 Australia PCR market, by product, 2018 - 2030 (USD Million)
  • Table 53 Australia PCR market, by application, 2018 - 2030 (USD Million)
  • Table 54 South Korea PCR market, by type, 2018 - 2030 (USD Million)
  • Table 55 South Korea PCR market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Korea PCR market, by application, 2018 - 2030 (USD Million)
  • Table 57 Latin America PCR market, by Country, 2018 - 2030 (USD Million)
  • Table 58 Latin America PCR market, by type, 2018 - 2030 (USD Million)
  • Table 59 Latin America PCR market, by product, 2018 - 2030 (USD Million)
  • Table 60 Latin America PCR market, by application, 2018 - 2030 (USD Million)
  • Table 61 Brazil PCR market, by type, 2018 - 2030 (USD Million)
  • Table 62 Brazil PCR market, by product, 2018 - 2030 (USD Million)
  • Table 63 Brazil PCR market, by application, 2018 - 2030 (USD Million)
  • Table 64 Mexico PCR market, by type, 2018 - 2030 (USD Million)
  • Table 65 Mexico PCR market, by product, 2018 - 2030 (USD Million)
  • Table 66 Mexico PCR market, by application, 2018 - 2030 (USD Million)
  • Table 67 Argentina PCR market, by type, 2018 - 2030 (USD Million)
  • Table 68 Argentina PCR market, by product, 2018 - 2030 (USD Million)
  • Table 69 Argentina PCR market, by application, 2018 - 2030 (USD Million)
  • Table 70 Middle East & Africa PCR market, by Country, 2018 - 2030 (USD Million)
  • Table 71 Middle East & Africa PCR market, by type, 2018 - 2030 (USD Million)
  • Table 72 Middle East & Africa PCR market, by product, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa PCR market, by application, 2018 - 2030 (USD Million)
  • Table 74 South Africa PCR market, by type, 2018 - 2030 (USD Million)
  • Table 75 South Africa PCR market, by product, 2018 - 2030 (USD Million)
  • Table 76 South Africa PCR market, by application, 2018 - 2030 (USD Million)
  • Table 77 Saudi Arabia PCR market, by type, 2018 - 2030 (USD Million)
  • Table 78 Saudi Arabia PCR market, by product, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia PCR market, by application, 2018 - 2030 (USD Million)
  • Table 80 UAE PCR market, by type, 2018 - 2030 (USD Million)
  • Table 81 UAE PCR market, by product, 2018 - 2030 (USD Million)
  • Table 82 UAE PCR market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 PCR market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 PCR market snapshot
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook, revenue, 2021, USD Billion
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 PCR market driver impact
  • Fig. 14 PCR market restraint impact
  • Fig. 15 SWOT analysis, by a factor (Political & legal, economic, and technological)
  • Fig. 16 Industry Analysis - Porter's
  • Fig. 17 Strategy mapping
  • Fig. 18 PCR market - Unmet needs analysis
  • Fig. 19 Consumer behavior analysis
  • Fig. 20 PCR market: Type outlook and key takeaways
  • Fig. 21 PCR market: Type movement analysis & market share 2021 & 2030
  • Fig. 22 Conventional PCR market estimates and forecast, 2018 - 2030(USD Million)
  • Fig. 23 Others market estimates and forecast, 2018 - 2030(USD Million)
  • Fig. 24 PCR market: Product outlook and key takeaways
  • Fig. 25 PCR market: Product movement analysis & market share 2021 & 2030
  • Fig. 26 Consumables & reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Software & services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 PCR market: Application outlook and key takeaways
  • Fig. 30 PCR market: Application movement analysis & market share 2021 & 2030
  • Fig. 31 Medical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Clinical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Pathogen testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Oncology testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Blood screening market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 36 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Research market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Forensics and others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Non-medical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Food market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 PCR market: Regional outlook and key takeaways
  • Fig. 43 Regional outlook, 2021 & 2030
  • Fig. 44 North America
  • Fig. 45 North America. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 U.S.
  • Fig. 47 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Canada
  • Fig. 49 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Europe
  • Fig. 51 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 U.K.
  • Fig. 53 U.K. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Germany
  • Fig. 55 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 France
  • Fig. 57 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Italy
  • Fig. 59 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Spain
  • Fig. 61 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Asia Pacific
  • Fig. 63 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Japan
  • Fig. 65 Japan market estimates and forecast, 2018 - 2030(USD Million)
  • Fig. 66 China
  • Fig. 67 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 India
  • Fig. 69 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea
  • Fig. 71 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Australia
  • Fig. 73 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Latin America
  • Fig. 75 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Brazil
  • Fig. 77 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Mexico
  • Fig. 79 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Argentina
  • Fig. 81 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Middle East & Africa
  • Fig. 83 MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 South Africa
  • Fig. 85 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Saudi Arabia
  • Fig. 87 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 UAE
  • Fig. 89 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Ansoff Matrix
  • Fig. 91 Market differentiators
  • Fig. 92 Key company market share analysis, 2021
  • Fig. 93 Company market position analysis
  • Fig. 94 Company market position analysis
  • Fig. 95 Competitive dashboard analysis
  • Fig. 96 Regional network map